A Rhode Island man on Wednesday got the first transfusion of a newly approved drug to treat Alzheimers — despite questions over the drug’s cost and effectiveness.
Mark Archambault, 70, is the first … [+2370 chars]
First patient given controversial new Alzheimers treatment drug – New York Post
